Bio-Techne (TECH) Revenue — Quarter Ended Mar 31, 2023
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year. The sequential growth was more pronounced than the year-over-year gain.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q3
Revenue for the quarter increased compared to both the prior quarter and the same quarter last year. The sequential growth was more pronounced than the year-over-year gain.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$294.1M
Revenue reported for this quarter.
Quarter-over-quarter
+8.3%
Change from the immediately preceding quarter.
Year-over-year
+1.3%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.1B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $288.2M | +11.3% |
| Sep 30, 2022 | $269.7M | +4.6% |
| Dec 31, 2022 | $271.6M | +0.9% |
| Mar 31, 2023 | $294.1M | +1.3% |
Revenue performance
The reported revenue rose from the immediately preceding quarter, continuing an upward trajectory seen in recent periods.
Quarterly comparison
Compared to the same quarter one year earlier, revenue also increased, though at a slower pace than the sequential improvement.
What to watch
The filing context does not provide specific commentary on revenue drivers for this quarter.